CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Current assets    
Cash and cash equivalents $ 718 $ 1,011
Other current assets 225 247
Total current assets 943 1,258
Patent license rights, net 470 509
Furniture and equipment, net 0 0
Total assets 1,413 1,767
Current liabilities    
Accounts payable 173 254
Other accrued liabilities 93 7
Total current liabilities 266 261
Convertible Promissory Notes Payable 1,000 1,000
Capstone Therapeutics Corp. Stockholders' Equity    
Common Stock $.0005 par value; 150,000,000 shares authorized; 40,885,411 shares in 2016 and 2015 issued and outstanding 20 20
Additional paid-in capital 189,462 189,442
Accumulated deficit (189,335) (188,956)
Total Capstone Therapeutics Corp. stockholders' equity 147 506
Noncontrolling interest 0 0
Total equity 147 506
Total liabilities and equity $ 1,413 $ 1,767